Junichi Inokuchi

Professor

Graduate School of Medicine, University of the Ryukyus

Japan

Research Interests

Explore related searches

Professors in Japan Professors in Cancer Biology Cancer Biology professors in Japan

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Junichi Inokuchi is a Professor at the Graduate School of Medicine, University of the Ryukyus, Japan. His research primarily focuses on oncology, particularly in bladder and prostate cancers, with significant contributions in the areas of biomarkers, cancer treatment outcomes, and therapeutic targets. Recent articles include studies on the prognosis of upper urinary tract cancers and the effects of genetic factors on cancer progression.

Articles (10)

Year:

2023

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (2)

Takashi Kobayashi

JAPAN

View details

KIYOHIDE FUJIMOTO

Professor and Chair

Nara Medical University

JAPAN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Junichi Inokuchi

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Subsequent Upper Urinary Tract Carcinoma Related to Worse Survival in Patients Treated with BCG

Protein Kinase C (PKC) Isozymes as Diagnostic and Prognostic Biomarkers and Therapeutic Targets for Cancer

Identification of Activated Protein Kinase Cα (PKCα) in the Urine of Orthotopic Bladder Cancer Xenograft Model as a Potential Biomarker for the Diagnosis of Bladder Cancer

Gene amplification of YB-1 in castration-resistant prostate cancer in association with aberrant androgen receptor expression

Significance of the timing of ureteral ligation on prognosis during radical nephroureterectomy for upper urinary tract urothelial cancer

Effect of Smoking on Oncological Outcome among Prostate Cancer Patients after Radical Prostatectomy with Neoadjuvant Hormonal Therapy

High-throughput screen identifies 5-HT receptor as a modulator of AR and a therapeutic target for prostate cancer

Impact of antiandrogen withdrawal syndrome in castration-resistant prostate cancer patients treated with abiraterone or enzalutamide

Perioperative therapies for urological cancers

Polymorphisms in androgen metabolism genes with serum testosterone levels and prognosis in androgen-deprivation therapy

Collaborators (2)

Takashi Kobayashi

KIYOHIDE FUJIMOTO

Make your next move.